121 related articles for article (PubMed ID: 35803876)
1. Antivenoms, hepatitis B vaccine and oral polio vaccine can be considered for storage and handling outside the cold chain following the innovative 'controlled temperature chain' approach.
Mohamed SH; Hady OA; Kashef MT; Zedan H
Biologicals; 2022 Jul; 78():27-35. PubMed ID: 35803876
[TBL] [Abstract][Full Text] [Related]
2. Caution needed in using oral polio vaccine beyond the cold chain: vaccine vial monitors may be unreliable at high temperatures.
Shrivastava A; Gupta N; Upadhyay P; Puliyel J
Indian J Med Res; 2012 Apr; 135(4):520-2. PubMed ID: 22664500
[TBL] [Abstract][Full Text] [Related]
3. The impact of different IPV-OPV sequential immunization programs on hepatitis A and hepatitis B vaccine efficacy.
Chen S; Zhao Y; Yang Z; Li Y; Shi H; Zhao T; Yang X; Li J; Li G; Wang J; Ying Z; Yang J
Hum Vaccin Immunother; 2022 Dec; 18(1):2024063. PubMed ID: 35044877
[TBL] [Abstract][Full Text] [Related]
4. Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad.
Zipursky S; Boualam L; Cheikh DO; Fournier-Caruana J; Hamid D; Janssen M; Kartoglu U; Waeterloos G; Ronveaux O
Vaccine; 2011 Aug; 29(34):5652-6. PubMed ID: 21699946
[TBL] [Abstract][Full Text] [Related]
5. Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
Petit D; Tevi-Benissan C; Woodring J; Hennessey K; Kahn AL
Vaccine; 2017 Dec; 35(49 Pt B):6866-6871. PubMed ID: 29132994
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.
Breakwell L; Anga J; Dadari I; Sadr-Azodi N; Ogaoga D; Patel M
Vaccine; 2017 May; 35(21):2770-2774. PubMed ID: 28431814
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR.
Kolwaite AR; Xeuatvongsa A; Ramirez-Gonzalez A; Wannemuehler K; Vongxay V; Vilayvone V; Hennessey K; Patel MK
Vaccine; 2016 Jun; 34(28):3324-30. PubMed ID: 27040399
[TBL] [Abstract][Full Text] [Related]
8. Using oral polio vaccine beyond the cold chain: a feasibility study conducted during the national immunization campaign in Mali.
Halm A; Yalcouyé I; Kamissoko M; Keïta T; Modjirom N; Zipursky S; Kartoglu U; Ronveaux O
Vaccine; 2010 Apr; 28(19):3467-72. PubMed ID: 20197147
[TBL] [Abstract][Full Text] [Related]
9. Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains.
Cai W; Ping L; Shen W; Liu J; Zhang M; Zhou J; Peng J; Wang M; Zhu Y; Ji G; Wang X; Ji Q; Lai C; Shi L; Che Y; Sun M
Hum Vaccin Immunother; 2020 Aug; 16(8):1866-1874. PubMed ID: 32118517
[TBL] [Abstract][Full Text] [Related]
10. Are childhood immunization programmes in Australia at risk? Investigation of the cold chain in the Northern Territory.
Miller NC; Harris MF
Bull World Health Organ; 1994; 72(3):401-8. PubMed ID: 8062398
[TBL] [Abstract][Full Text] [Related]
11. Storage and handling of vaccines by family doctors.
Finnegan P; Howell F
Ir Med J; 1996; 89(2):64-6, 68. PubMed ID: 8682634
[TBL] [Abstract][Full Text] [Related]
12. Improving birth dose coverage of hepatitis B vaccine.
Hipgrave DB; Maynard JE; Biggs BA
Bull World Health Organ; 2006 Jan; 84(1):65-71. PubMed ID: 16501717
[TBL] [Abstract][Full Text] [Related]
13. Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.
Shin WJ; Hara D; Gbormittah F; Chang H; Chang BS; Jung JU
mBio; 2018 Nov; 9(6):. PubMed ID: 30482835
[TBL] [Abstract][Full Text] [Related]
14. Cold chain monitoring of OPV at transit levels in India: correlation of VVM and potency status.
Jain R; Sahu AK; Tewari S; Malik N; Singh S; Khare S; Bhatia R
Biologicals; 2003 Dec; 31(4):237-44. PubMed ID: 14624793
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for improper vaccine storage and handling in private provider offices.
Bell KN; Hogue CJ; Manning C; Kendal AP
Pediatrics; 2001 Jun; 107(6):E100. PubMed ID: 11389298
[TBL] [Abstract][Full Text] [Related]
16. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
Xiao Y; Daniell H
Vaccine; 2017 Sep; 35(40):5418-5425. PubMed ID: 28111147
[TBL] [Abstract][Full Text] [Related]
17. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
[TBL] [Abstract][Full Text] [Related]
18. Relationship between vaccine vial monitors and cold chain infrastructure in a rural district of India.
Samant Y; Lanjewar H; Parker L; Block D; Stein B; Tomar G
Rural Remote Health; 2007; 7(1):617. PubMed ID: 17288508
[TBL] [Abstract][Full Text] [Related]
19. Cold-Chain Adaptability During Introduction of Inactivated Polio Vaccine in Bangladesh, 2015.
Billah MM; Zaman K; Estivariz CF; Snider CJ; Anand A; Hampton LM; Bari TIA; Russell KL; Chai SJ
J Infect Dis; 2017 Jul; 216(suppl_1):S114-S121. PubMed ID: 28838173
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam.
Hipgrave DB; Tran TN; Huong VM; Dat DT; Nga NT; Long HT; Van NT; Maynard JE; Biggs BA
Am J Trop Med Hyg; 2006 Feb; 74(2):255-60. PubMed ID: 16474080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
